Article

Parry becomes new AMDAI chairman

Hugh R. Parry has been named chairman of the board of AMD Alliance International (AMDAI), an international organization dedicated exclusively to macular disease.Parry, president and CEO of Prevent Blindness America, was appointed during the annual board meeting of AMDAI in New York on April 16, 2010.

Chicago-Hugh R. Parry has been named chairman of the board of AMD Alliance International (AMDAI), an international organization dedicated exclusively to macular disease.

Parry, president and CEO of Prevent Blindness America, was appointed during the annual board meeting of AMDAI in New York on April 16, 2010.

AMDAI is a consortium of 70 of the world's leading vision, seniors, and research organizations in 25 countries. Its goal is to bring knowledge, hope, and help to individuals and families around the globe affected by age-related macular degeneration (AMD). There are 30 million people affected by AMD worldwide and that number is predicted to triple over the next 10 years given the aging population.

“Eye diseases, such as macular degeneration, cross all borders,” said Parry. “I am honored to be chosen to chair this organization of dedicated individuals from around the world so that we may put forth a collaborative effort to help put an end to unnecessary vision loss.”

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.